A breakthrough study published in Clinical and Translational Gastroenterology, the official journal of the ACG, showcases ProPhase Labs’ BE-Smart —…
Browsing: Clinical Updates
Results from GRAIL’s registrational PATHFINDER 2 study, presented at ESMO 2025, show that adding the Galleri multi-cancer early detection (MCED)…
A new study in Current Medical Research and Opinion found that eliminating patient cost sharing for follow-up colonoscopy after a…
Objective: To assess how the use of different colorectal cancer (CRC) screening methods changed in the U.S. between 2017 and…
With GLP-1 supply stabilizing after a 600% surge in U.S. use between 2018–2024, the obesity treatment market is on the…
New peer-reviewed data in Practical Laboratory Medicine confirms the analytical reliability of Geneoscopy’s scrape-free collection method used in the FDA-approved…
A JNCI decision-modeling study compared noninvasive colorectal cancer screening options using “efficient frontiers” (benefit: life-years or QALYs gained; burden: lifetime…
A new review in Nature Mental Health strengthens the case that the gut microbiome directly shapes brain chemistry, stress responses,…
OncoDaily GI spotlights the innovations transforming gastrointestinal oncology — from precision biomarkers to advances in equitable cancer care. The second…
The FDA has requested the withdrawal of obeticholic acid (Ocaliva), used to treat primary biliary cholangitis (PBC). Manufacturer Intercept Pharmaceuticals…